0.5429

3.05% -0.0171

After Hours: .56 0.0171 +3.15%

Mustang Bio Inc (MBIO)

Overview News Price History Financials Why MBIO Down? Discussions Forecast Stock Split

Mustang Bio Inc stock is traded at $0.5429, with a volume of 37,376. It is down -3.05% in the last 24 hours and down -8.60% over the past month. Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Previous Close:

$0.56

Open:

$0.553299

24h Volume:

37,376

Relative Volume:

0.36

Market Cap:

$4.11M

Revenue:

Net Income/Loss:

$-2.72M

P/E Ratio:

-1.1308

EPS:

-0.4801

Net Cash Flow:

$-4.88M

1W Performance:

+0.99%

1M Performance:

-8.60%

6M Performance:

-43.36%

1Y Performance:

-63.07%

1-Day Range:

$0.5322

$0.5582

1-Week Range:

$0.5322

$0.5609

52-Week Range:

$0.525

$1.85

Mustang Bio Inc Stock (MBIO) Company Profile

Name

Mustang Bio Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

(781) 652-4500

Address

95 SAWYER RD, WALTHAM, NY

Employee

Twitter

@Mustang_Bio

Next Earnings Date

2026-08-14

Latest SEC Filings

MBIO's Discussions on Twitter

Compare MBIO vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MBIO Mustang Bio Inc	0.5429	4.34M	0	-2.72M	-4.88M	-0.4801
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-18-21	Initiated	BTIG Research	Buy
Oct-02-20	Initiated	B. Riley FBR	Buy
Nov-20-19	Initiated	Cantor Fitzgerald	Overweight
Aug-13-19	Initiated	H.C. Wainwright	Buy
Jun-21-19	Initiated	Cantor Fitzgerald	Overweight
Dec-21-17	Initiated	Oppenheimer	Outperform

View All

Mustang Bio Inc Stock (MBIO) Latest News

Aug 20, 2026

Mustang (MBIO) EPS and Revenue: EPS Misses Its Estimate in the Latest Session; Market Response: The Market Price Moves 0.70% Higher in the Latest ReadingManagement Tone Analysis - vinanet.vn

Aug 20, 2026

Aug 18, 2026

Pediatrix (MD) Trading-Day Recap: Ends Higher by 0.84% at $26.56 on the Day; Level Position: Support at $25.23 and Resistance at $27.89 Frame the RangeReversal Trade - Vinanet

Aug 18, 2026

Aug 14, 2026

Mustang Bio Stock Price Forecast. Should You Buy MBIO? - StockInvest.us

Aug 14, 2026

Aug 12, 2026

BHE Q2 2026 Earnings: EPS Beats Estimates by 8.4% as Bottom-Line Strength Drives Shares HigherROIC Trend Report - Vinanet

Aug 12, 2026

Aug 11, 2026

Mustang Bio (MBIO) Edges Higher by 3% as Shares Test Key Resistance at $0.64Dark Pool Prints - Vinanet

Aug 11, 2026

Aug 10, 2026